FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015529888> ?p ?o ?g. }

• W2015529888 abstract "BACKGROUND: Temozolomide, the most important chemotherapeutic agent used in neurooncology, has moderate emetogenic potential. With the introduction of ondansetron, the first 5HT3-antagonist on the market, most of us neurooncologists thought that the problem of nausea and emesis was resolved. Some patients, however, report on severe nausea and vomiting during treatment. We therefore initiated a study on nausea and quality of life during chemotherapy of neurooncological diseases. METHODS: The MASCC questionnaire on nausea and emesis includes an 11-step scale on nausea and frequency of vomiting. We midified it with a visual analogue scale and ask patients to fill this in one day before and 10 days from the start of chemotherapy for 2 cycles. Additional questions aks for anticipatory vomiting. In order to assess a possible influence of depressive symptoms and the impact of chemotherapy on quality of life, EORTC QLQ-C30 with BN20 and health questionnaire 9 are asked to be filled in once before and for two cycles during chemotherapy.RESULTS: At abstract submission, 17 patients treated with temozolomide were included. The absolute doses of temozolomide ranged from 60 to 420mg, according to the respective dosing regimen. Antiemetic treatment included aliprazide 50mg, ondansetrone 8mg, granisetrone 2mg or palonosetrone 0.5mg. Two thirds of patients (12/17) did not suffer from nausea and emesis. Relevant nausea only occurred at doses of 200mg or more of temozolomide. With aliprazide, the maximal intensity of nausea of 10 at the visual analogue scale was already reached with 200mg of temozolomide day 1. By contrast, maximal values of only 7 occurred with ondansetrone and granisetrone with a delayed peak at day 3. With palonosetrone, max. values of 4 were reached at day 3 even with 420mg of temozolomide. Of note, nausea often persisted for 2-3 days after application of temozolomide.CONCLUSIONS: To our knowledge, this is the first study to assess nausea and emesis over a longer period of time. The preliminary analysis already shows marked differences between patients, depending from the dose of temozolomide and the antiemetic regimen. The intensity can be maximal and the duration longer than the application of chemotherapy. This demonstrates that nausea and emesis can be more intense than generally noted and should carefully be asked for and treated with long lasting antiemetics. Updated results of this ongoing study with more patients included and more detailed subgroup analysis will be presented." @default.
• W2015529888 created "2016-06-24" @default.
• W2015529888 creator A5032411392 @default.
• W2015529888 creator A5070509685 @default.
• W2015529888 creator A5089692811 @default.
• W2015529888 date "2014-09-01" @default.
• W2015529888 modified "2023-09-23" @default.
• W2015529888 title "P15.18 * NAUSEA AND EMESIS DURING NEUROONCOLOGICAL CHEMOTHERAPY - PROBLEM RESOLVED WITH ANY SETRONE?" @default.
• W2015529888 doi "https://doi.org/10.1093/neuonc/nou174.297" @default.
• W2015529888 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4185657" @default.
• W2015529888 hasPublicationYear "2014" @default.
• W2015529888 type Work @default.
• W2015529888 sameAs 2015529888 @default.
• W2015529888 citedByCount "2" @default.
• W2015529888 countsByYear W20155298882015 @default.
• W2015529888 countsByYear W20155298882019 @default.
• W2015529888 crossrefType "journal-article" @default.
• W2015529888 hasAuthorship W2015529888A5032411392 @default.
• W2015529888 hasAuthorship W2015529888A5070509685 @default.
• W2015529888 hasAuthorship W2015529888A5089692811 @default.
• W2015529888 hasBestOaLocation W20155298881 @default.
• W2015529888 hasConcept C126322002 @default.
• W2015529888 hasConcept C2776694085 @default.
• W2015529888 hasConcept C2777170512 @default.
• W2015529888 hasConcept C2777389519 @default.
• W2015529888 hasConcept C2780574406 @default.
• W2015529888 hasConcept C2780580376 @default.
• W2015529888 hasConcept C2780852908 @default.
• W2015529888 hasConcept C2780884295 @default.
• W2015529888 hasConcept C42219234 @default.
• W2015529888 hasConcept C71924100 @default.
• W2015529888 hasConceptScore W2015529888C126322002 @default.
• W2015529888 hasConceptScore W2015529888C2776694085 @default.
• W2015529888 hasConceptScore W2015529888C2777170512 @default.
• W2015529888 hasConceptScore W2015529888C2777389519 @default.
• W2015529888 hasConceptScore W2015529888C2780574406 @default.
• W2015529888 hasConceptScore W2015529888C2780580376 @default.
• W2015529888 hasConceptScore W2015529888C2780852908 @default.
• W2015529888 hasConceptScore W2015529888C2780884295 @default.
• W2015529888 hasConceptScore W2015529888C42219234 @default.
• W2015529888 hasConceptScore W2015529888C71924100 @default.
• W2015529888 hasLocation W20155298881 @default.
• W2015529888 hasLocation W20155298882 @default.
• W2015529888 hasOpenAccess W2015529888 @default.
• W2015529888 hasPrimaryLocation W20155298881 @default.
• W2015529888 hasRelatedWork W1482299335 @default.
• W2015529888 hasRelatedWork W1923473010 @default.
• W2015529888 hasRelatedWork W196471322 @default.
• W2015529888 hasRelatedWork W1978017209 @default.
• W2015529888 hasRelatedWork W1993035455 @default.
• W2015529888 hasRelatedWork W2014291671 @default.
• W2015529888 hasRelatedWork W2092292817 @default.
• W2015529888 hasRelatedWork W2140767828 @default.
• W2015529888 hasRelatedWork W2147149737 @default.
• W2015529888 hasRelatedWork W2148594906 @default.
• W2015529888 hasRelatedWork W2190560399 @default.
• W2015529888 hasRelatedWork W2362228278 @default.
• W2015529888 hasRelatedWork W2613346350 @default.
• W2015529888 hasRelatedWork W2799403577 @default.
• W2015529888 hasRelatedWork W2802423307 @default.
• W2015529888 hasRelatedWork W2811346424 @default.
• W2015529888 hasRelatedWork W2896398840 @default.
• W2015529888 hasRelatedWork W2904007992 @default.
• W2015529888 hasRelatedWork W2936727028 @default.
• W2015529888 hasRelatedWork W2553098477 @default.
• W2015529888 isParatext "false" @default.
• W2015529888 isRetracted "false" @default.
• W2015529888 magId "2015529888" @default.
• W2015529888 workType "article" @default.